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ABSTRAK
Latar belakang: penyakit kardiovaskular sangat umum dan bisa berakibat fatal pada pasien usia lanjut. Hal 
ini sering diawali oleh disfungsi sistolik ventrikel kiri (LVSD) asimptomatik atau subklinis. Deteksi dini LVSD dapat 
mengurangi morbiditas dan mortalitas akibat penyakit kardiovaskular. Salah satu metode yang digunakan dalam 
deteksi dini LVSD adalah penilaian global longitudinal strain (GLS). Penelitian ini bertujuan untuk menentukan nilai 
rerata faktor GLS dan terkait GLS. Metode: penelitian cross-sectional dilakukan di antara pasien usia lanjut berusia 
>60 tahun di poliklinik geriatri dan kardiologi, Departemen Ilmu Penyakit Dalam, RS Cipto Mangunkusumo. Data 
diperoleh dengan menggunakan metode wawancara, rekam medis, dan pemeriksaan ekokardiografi transthoracic. 
Variabel usia, frailty, hipertensi, penyakit arteri koroner, dislipidemia, dan diabetes mellitus dianalisis sebagai 
faktor penentu penurunan GLS. Analisis univariat dilakukan untuk setiap variabel. Analisis bivariat dilakukan 
dengan menggunakan uji chi-square dengan signifikansi p<0,25 dan interval kepercayaan (CI) 95%, dan analisis 
multivariat menggunakan uji regresi logistik. Hasil: sebanyak 194 pasien dirawat sesuai dengan kriteria penelitian, 
usia rerata 66 tahun. Proporsi wanita adalah 60,8%. Studi ini mengungkapkan bahwa faktor penentu dengan p<0,25 
adalah frailty, hipertensi, dislipidemia, dan diabetes mellitus, dengan analisis multivariat frailty memperoleh nilai 
OR 2,002 (95% CI 1,042-3,925) dan diabetes mellitus memiliki OR 2,8278 (95% CI) 1.033–5.025). Kesimpulan: 
nilai rerata GLS pada orang tua adalah -21,6% (nilai minimum -5,3% dan nilai maksimum 29,9%). Faktor-faktor 
yang mempengaruhi penurunan GLS adalah frailty dan diabetes mellitus.
Kata kunci: global longitudinal strain (GLS), disfungsi sistolik ventrikel kiri (LVSD), frailty.
ABSTRACT
Background: cardiovascular disease is very common and can be fatal in elderly patients. It is often preceded 
by asymptomatic or subclinical left ventricular systolic dysfunction (LVSD). Early detection of LVSD can reduce 
morbidity and mortality due to cardiovascular disease. One method used in the early detection of LVSD is an 
assessment of global longitudinal strain (GLS). This study aimed to determine the mean value of GLS and GLS-
related factors. Methods: this cross-sectional study was conducted among elderly patients aged > 60 years in 
the geriatric and cardiology clinic, Internal Medicine, CMH Hospital. Data were obtained from interviews, 
medical records, and transthoracic echocardiography examination. The variables of age, frailty, hypertension, 
coronary artery disease, dyslipidemia, and diabetes mellitus were analyzed as the determinants of a decrease 
in GLS. Univariate analysis was conducted for each variable. Bivariate analysis was conducted using the chi-
square test with a significance level of p<0.25 and confidence interval (CI) of 95%, and multivariate analysis 
used a logistic regression test. Results: a total of 194 patients were admitted according to the study criteria, with 
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a mean age of 66 years. The proportion of women was 60.8%. The study revealed that the determinants with 
p<0.25 are frailty, hypertension, dyslipidemia, and diabetes mellitus, with multivariate analysis frailty having 
an OR of 2.002 (95% CI 1.042–3.925) and diabetes mellitus having an OR of 2.278 (95% CI 1.033–5.025). 
Conclusion: the mean value of GLS among the elderly was -21.6% (minimum value -5.3% and maximum value 
29.9%). The factors that influence the decrease of GLS are frailty and diabetes mellitus.
Keywords: global longitudinal strain (GLS), left ventricular systolic dysfunction (LVSD), frailty.
INTRODUCTION
Cardiovascular disease is very common and 
potentially fatal in elderly patients. Heart failure 
is the end stage of all cardiovascular diseases and 
is often preceded by asymptomatic or subclinical 
left ventricular systolic dysfunction (LVSD).1,2 
Subclinical LVSD is LVSD without the signs 
and symptoms of heart failure detected by global 
longitudinal strain (GLS).3 It can be classified 
as stage A and B heart failure according to the 
American College of Cardiology/American 
Heart Association 2013.4 The early detection of 
LVSD prior to it developing into heart failure 
can reduce morbidity and mortality due to 
cardiovascular diseases.5 Subclinical LVSD 
management is currently controversial as it is 
a new event that requires further research and 
adjustment to the stage of heart failure obtained.6
LVSD can be diagnosed by measuring the 
left ventricular ejection fraction (LVEF), which 
progressively decreases with age. However, 
LVEF examination is not sensitive to subclinical 
LVSD assessment.7,8 One potential early detection 
method that can be carried out is to measure 
echocardiography using the speckle tracking 
echocardiography (STE) method. Using this 
STE method, the strain ability of the heart 
muscle can be assessed by evaluating GLS. A 
decrease in GLS is generally caused by a change 
in left ventricular geometry with or without any 
accompanying damage to or decrease in the 
left ventricular function. GLS is thus able to 
provide an early assessment of changes in the left 
ventricular systolic function when LVEF is still 
within normal limits.9-11 Other factors that may 
affect a decrease in GLS values are changes in 
left ventricular geometry associated with various 
comorbidities: (1) Type 2 diabetes mellitus 
presents a 2.26 times greater risk of a decrease 
in GLS compared to patients without type 2 
diabetes mellitus; (2) Hypertension is closely 
related to a decrease in GLS. Patients that have 
been hypertensive for more than 10 years have a 
3.51 times greater risk of a decrease in GLS, while 
patients with uncontrolled hypertension are at a 
3.55 times greater risk of a decrease in GLS; (3) 
Dyslipidemia presents a 2.26 times greater risk of 
a decrease in GLS compared to patients without 
dyslipidemia.10,11 Dyslipidemia is a single major 
risk factor of coronary artery disease (CAD). CAD 
also affects a decrease in GLS.12 A study by Liou 
et al. found that GLS can be used to detect CAD 
in symptomatic patients.13 The management of 
various risk factors and diseases will inhibit the 
process of the disease becoming symptomatic 
heart failure.12
Cardiovascular dysfunction plays an 
important role in the development of frailty. 
Frailty is a condition in which there is an increased 
susceptibility to stressors that causes multisystem 
dysregulation. It is influenced by age and is 
associated with a high risk of physical dysfunction 
and increased mortality in the elderly.14 A study 
by Russo et al.15 found that black ethnicity was 
associated with a greater degree of subclinical 
LVSD by GLS than for other race-ethnic groups. 
Other study, meanwhile, have shown the existence 
of reference ranges based on age, gender, and 
ethnicity. The data for the research were gathered 
from Africans, Americans, Asians, Australians, 
and those of Middle Eastern and Pacific descent. 
However, based on the research, Indonesian 
data is not yet known.16 We sought to investigate 
the relationship between GLS, elderly and its 
comorbidities.
METHODS
This is an observational study with a cross-
sectional design with the aim of adding data on 
GLS in elderly patients and its related factors. The 
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data were collected from elderly patients aged > 
60 years old in the geriatric and cardiology clinic, 
Internal Medicine, CMH Hospital. Data were 
obtained from interviews, medical records, and 
transthoracic echocardiography examinations, 
using the consecutive sampling method, from 
December 2018 to April 2019. This study was 
approved by the Ethics Committee, Faculty of 
Medicine, Universitas Indonesia, with ethical 
approval no. 1212/UN2.F1/ETIK/2018.
Registered patients at the geriatric and 
cardiology clinic aged >60 years old who 
met the inclusion criteria of having one of 
the comorbidities needed in this study were 
included. The comorbidities for inclusion were 
hypertension, CAD, dyslipidemia, and diabetes 
mellitus. Meanwhile, any patients who had 
symptomatic heart disease, were involved in drug 
research, had pulmonary diseases and kidney 
disorders (stage 4 and 5 chronic kidney disease), 
had arrhythmia, had poor echo window, and who 
were unwilling to take part in the study were 
excluded. The subjects were given oral and written 
explanations regarding the study and were asked 
to sign an informed consent form. Frailty was 
determined based on a questionnaire comprising 
a 40-item frailty index. Echocardiography 
was carried out by one operator (MSA), with 
two operators (SAN, LR) who already had the 
echocardiography examination certification 
providing confirmation of the post-processing 
data. The results were recorded and analyzed.
Data Analysis
A data normality test was conducted using 
the Kolmogorov-Smirnov test. The variables 
of age, frailty, hypertension, coronary artery 
disease, dyslipidemia, and diabetes mellitus 
were analyzed as the determinants of a decrease 
in GLS. Univariate analysis was carried out 
in respect of each variable. Bivariate analysis 
was undertaken using a chi-square test with 
a significance level of p<0.25 and confidence 
interval (CI) of 95%, and multivariate analysis 
was carried out using a logistic regression test.
RESULTS
From a total of 203 patients who met the 
inclusion criteria, 9 were excluded owing to the 
presence of arrhythmia and poor echo window, 
which resulted in 194 research subjects meeting 
the criteria for analysis in this study. These 194 
patients consisted of 76 males (38.2%) and 118 
females (60.8%). The median age in this study 
is 66 years, with a range of 60–90 years old. A 
total of 184 patients (94.8%) have LVEF within 
normal limits, and 10 patients (5.2%) have 
decreased LVEF. The GLS assessment shows 
that 135 patients (69.6%) are within normal 
limits, while 57 patients (29.4%) have decreased 
GLS. Some of the patients with normal LVEF 
have decreased GLS. Frailty was present for 85 
patients (43.8%), with non-frailty present in 109 
patients (56.2%). In this study, 34 patients have 
CAD (17.5%), 149 have hypertension (76.8%), 
105 have dyslipidemia (54.1%), and 44 patients 
have diabetes mellitus (22.7%).
From the echocardiography results, the 
measurements of Interventricular Thickness End-
Diastole (IVSD), Left Ventricular Dimension 
End-Diastole (LVDD), and Left Ventricular 
Posterior Wall (LVPW) have average values of 
1.26 cm, 4.39 cm, and 1.07 cm, respectively. 
The measurements of Left Atrial End-systolic 
Volume Index (LAVI) and E/A display average 
values of 28.40 ml/m2 and 0.80, respectively. The 
Table 1. Characteristic of subjects
Characteristics N (%)
Gender, n (%)
 - Women 118 (60.8)
Age, median (min-max) 66 (60-90)
 - Young-old, n (%) 161 (83.0)
LVEF, median (min-max) 66 (24.7 - 82.2)
 - Normal (≥ 55 %), n (%) 184 (94.8) 
GLS, median (min-max) 21,6 (5.3 - 29.9)
 - Normal (≥ -20 %), n 
(%)
135 (69.6)
Frailty index, median (min-
max)
0.22 (0.03-0.9)
 - Frailty (≥0,24), n (%) 85 (43.8)
CAD, n (%)
 - Yes 34 (17.5)
Hypertension, n (%)
 - Yes 149 (76.8)
Dyslipidemia, n (%)
 - Yes 105 (54.1)
Diabetes Mellitus, n (%)
 - Yes 44 (22.7)
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measurements of Ejection Fraction 4-Chamber 
(EF4C), Ejection Fraction Biplane (EFBp), 
Global Longitudinal Strain (GLS) and Tricuspid 
Annular Plane Systolic Excursion (TAPSE) have 
average values of 65.45%, 65.03%, -21.60%, and 
28.40%, respectively. 
From the bivariate analysis, this study 
revealed some determinants that have p<0.25; 
these are frailty, hypertension, dyslipidemia, and 
diabetes mellitus.
The multivariate analysis shows that frailty 
has an OR of 2.002 (95% CI 1.042–3.925) and 
diabetes mellitus has an OR of 2.278 (95% CI 
1.033–5.025).
DISCUSSION
The patients in this study were predominantly 
female, with a proportion of 60.8% compared to 
the males. A study by Bendiab et al.17 reported no 
significant difference between males and females 
on GLS changes. The age range of the patients in 
this study was 60–90 years old with a median age 
of 66 years. This age range is not in accordance 
with various studies from all over the world. 
Nadruz et al.8, in a study using subjects with an 
average age of 75.6 (SD 5.0) years old, stated 
that elderly patients with frailty had a greater 
decrease in GLS. In addition, Hung et al.7 used 
subjects with an average age of 76 (SD 5) years 
in their study about the relationship between 
Table 2. Characteristics of echocardiographic features of research subjects
Characteristics Value Frailty Non frailty
Aorta diameter, cm (median) 2.50 (2.10-3.70) 2.50 2.50
Left Atrium, cm (mean) 3.56 (3.39-3.73) 3.43 3.46
E-Point Septal Separation, cm (median) 0.50 (0.20-1.40) 0.60 0.50
RV Dimension End-Diastole, cm (median) 1.97 (1.31-3.21) 1.97 2.01
IV Thickness End-Diastole, cm (mean) 1.26 (1.20-1.32) 1.23 1.22
LV Dimension End-Diastole, cm (mean) 4.39 (4.24-4.54) 4.29 4.49
LV Posterior Wall, cm (median) 1.07 (0.74-1.94) 1.06 1.00
LV Dimension End-Systole, cm (mean) 2.53 (2.41-2.64) 2.54 2.68
Fractional Shortening, % (median) 42.36 (16.80-52.70) 41.4 41.3
EF Teich, % (median) 75.00 (35.20-84.00) 72.7 74.15
Relative Wall Thickness (median) 0.50 (0.30-0.80) 0.50 0.40
LV Mass Index, g/m2 (mean) 110.50 (106.42-121.30) 111.69 113.54
Pulmonary Acceleration Time, ms (mean) 120.41 (114.05-126.76) 114.58 116.0
EF 4-Chamber, % (median) 65.45 (24.70-82.20) 66.70 65.6
EF Biplane, % (median) 65.03 (25.30-77.60) 66.50 65.2
GLS, % (median) -21.60 (-5.30 - -29.90) -20.80 -22
TV D-E Excursion, cm (mean) 2.48 (2.37-2.57) 2.43 2.38
LA End-systolic Volume Index, ml/m2 (mean) 28.40 (25.28-31.51) 28.12 27.23
IVC Expiration, cm (mean) 1.52 (1.45-1.57) 1.54 1.48
IVC Inspiration, cm (median) 0.68 (0.0-1.77) 0.69 0.69
Stroke Volume, ml (mean) 62.98 (57.94-68.03) 61.25 65.66
Cardiac Output, l/min (median) 4.30 (2.50-10.20) 4.2 4.35
Doppler Data
 - E, cm/s (mean) 76.65 (71.22-82.07) 73.67 76.69
 - A, cm/s (mean) 86.84 (81.68-92.01) 91.33 93.36
 - E/A (median) 0.80 (0.50-2.90) 0.70 0.80
 - E’ Medial, cm/s (mean) 6.87 (6.35-7.38) 6.47 7.81
 - E’ Lateral, cm/s (mean) 8.82 (8.20-9.44) 8.31 9.33
 - E/E’ (mean) 8.58 (8.01-9.15) 8.62 8.81
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age and sex and left ventricular remodeling. The 
differentiation in this study is that the younger 
ages were different from those in overseas 
studies. According to 2017 data from the United 
Nations, life expectancy in Indonesia falls within 
the range 65–69 years.
The results of the echocardiography 
measurements from IVSD, LVDD, and LVPW 
illustrate a thickening of the left ventricular 
wall, with the dimensions being within normal 
limits for geriatric patients. The LAVI and E/A 
measurements illustrate early onset of diastolic 
dysfunction in geriatric patients with E/A ≥ 0.80, 
with LAVI within normal limits. The patients’ 
measurements of EF4C, EFBp, GLS, and TAPSE 
are within normal limits. The LVEF measurement 
data show that 94.8% of the patients have normal 
LVEF, while 5.2% of the patients have decreased 
LVEF. The GLS measurement data show that 
69.6% of the patients have normal GLS, while 
30.4% of patients have decreased GLS. This 
reveals that 26.6% of patients with normal 
LVEF have decreased GLS. This is in line with 
a study by Yancy et al.2, which stated that there 
are elderly patients who have decreased GLS 
with normal LVEF. In this study, it was also 
found that a decrease in GLS has a sensitivity 
of 100%, a specificity of 73.4%, and a positive 
predictive value of 100% compared to the 
decrease in LVEF. Plana et al.18 stated that a 
decrease in GLS can predict subclinical LVSD 
before structural changes in the left ventricular 
and a decrease in LVEF, with high values for 
sensitivity, specificity, positive predictive value, 
and negative predictive value (65–96%, 73–95%, 
50–83%, and 89–97%).
In this study, based on bivariate analysis, 
age was not associated with a decrease in GLS. 
Table 3. Bivariate analysis for GLS deteminants
Variables
GLS
Total PR (95% CI) P value
Decreased (n,%) Normal (n,%)
Frailty
 - Frailty 31 (36.5) 54 (63.5) 85 1.728 1.092-2.735 0.018
 - Non-frailty 23 (21.1) 86 (78.9) 109
Usia
 - Old-old 6 (18.2) 27 (81.8) 33 0.610 0.285-1.306 0.174
 - Young-old 48 (29.8) 113 (70.2) 161
Hypertension
 - Yes 36 (24.2) 113 (75.8) 149 0.604 0.382-0.954 0.038
 - No 18 (40.0) 27 (60.0) 45
DM
 - Yes 17 (38.6) 27 (61.4) 44 1.566 0.983-2.495 0.069
 - No 37 (24.7) 113 (75.3) 150
CAD
 - Yes 8 (23.5) 26 (76.5) 34 0.818 0.426-1.573 0.675
 - No 46 (28.7) 114 (71.2) 160
Dyslipidemia
 - Yes 23 (21.9) 82 (78.1) 105 0.629 0.397-0.996 0.045
 - No 31 (34.8) 58 (65.2) 89
Table 4. Multivariate analysis for GLS determinants
B Coefficient
Standard 
error
Wald 
(Forward) Value p (Sig.) OR 95% CI
Frailty 0.704 0.338 4.332 0.037 2.002 1.042–3.925
DM 0.824 0.404 4.164 0.041 2.278 1.033-5.025
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with a PR of 2.880 and a p value of 0.289 (95% 
CI 0.443–18.749). Statistically, the age variable 
was not suitable to be continued to multivariate 
analysis due to the p value ≥0.25, although we 
did continue to multivariate analysis because it 
was clinically meaningful. This finding differs 
from that in a study by Hung et al.7, which stated 
that age should show a significant difference 
in terms of the decrease in GLS. Hung et al.7 
reported a decrease in GLS of 0.39–0.19% 
per decade. The value of GLS decreases every 
decade. In this study, the average GLS value for 
patients aged 60–70 years (n:141) was -21.08% 
(-7.4% – -29.9%), for patients aged 71–80 
years (n:43) it was -20.76% (-5.3% – -29.5%), 
while for patients aged 81–90 years (n:10) it 
was -22.88% (-16.8% – -26.20%). The higher 
average value for the oldest group may be due 
to the low number of subjects, which totaled 
only 10 patients.
This study showed a statistically significant 
relationship between frailty and a decrease in 
GLS, with an OR of 2.002 and a p value of 0.037 
(95% IK 1.042–3.925). This shows that patients 
with frailty have a 2.002 times greater risk of a 
decrease in GLS than non-frail patients. Seto 
et al.14 stated that cardiovascular dysfunction 
plays an important role in the development of 
frailty, which is the condition of being frail. The 
incidence of frailty increases with age, female 
gender, African-American race, low education 
and income, poor health, and the presence of 
chronic comorbid diseases and disability. Some 
of the subjects in this study have diseases such 
as hypertension, diabetes mellitus, coronary heart 
disease, and dyslipidemia. Pathophysiologically, 
frail elderly patients can display sarcopenia and 
weakness of limbs, resulting in a decrease in 
body activity, including for the cardiovascular 
system.19 A significant decrease in GLS has been 
shown in elderly patients without risk factors for 
cardiovascular disease, with a value of -20.9 (SD 
1.9) %.2 Elderly patients with frailty reported a 
greater decrease in GLS (22%) compared to the 
non-frail (12%).8
From the bivariate analysis, 24.2% of the 
patients with hypertension show a decrease 
in GLS, with a PR of 0.604 and a p value of 
0.038 (95% CI 0.382–0.954). Furthermore, 
multivariate analysis was carried out by logistic 
regression, although a p value of ≥0.05 meant it 
could not proceed to the multivariate final stage. 
This shows that hypertension is statistically not 
related to a decrease in GLS. However, this is not 
in accordance with a study by Bendiab et al.17, 
which stated that hypertension is closely related 
to a decrease in GLS. Hypertensive patients with 
a duration of more than 10 years have a 3.51 
times greater risk of a decrease in GLS, while 
patients with uncontrolled hypertension have a 
3.55 times greater risk of a decrease in GLS. This 
difference is likely to be due to the majority of the 
subjects in this study being hypertensive patients 
undergoing routine treatment. In this study, the 
average duration of hypertension is 8.6 years. 
Most of the patients were using a combination 
therapy of several drugs, with amlodipine being 
the most used drug. The mean blood pressure of 
the subjects was 133/81 mmHg, thus indicating 
that the subjects had controlled hypertension. 
The echocardiographic characteristics did not 
show a change in the structure due to severe 
hypertension, which could have produced a 
decrease in GLS values.
This study succeeded in revealing elements 
that were in accordance with the existing research 
on the relationship between diabetes mellitus and 
decreased GLS. Patients with diabetes mellitus 
have a 2.278 times greater risk of experiencing 
a decrease in GLS than patients without 
diabetes mellitus, with a p value of 0.041 (95% 
CI 1.033–5.025). These results indicate that 
diabetes mellitus is the most influential factor in 
decreasing GLS compared to the other studied 
factors. This finding is in accordance with that 
of Mahalle et al.10, who found that patients with 
diabetes mellitus have a 2.26 times greater risk of 
a decrease in GLS compared to patients without 
diabetes mellitus. Pathophysiologically, on the 
theoretical framework, diabetes mellitus causes 
a decrease in GLS in terms of macroangiopathy 
(coronary arteries) and microangiopathy (non-
ischemic cardiomyopathy). Diabetes mellitus 
and atherosclerosis-related cardiovascular events 
are also associated with comorbidities such as 
obesity, hypertension, and dyslipidemia. Diabetic 
cardiomyopathy is associated with an increase in 
adipocytes to release leptin and resistin, which 
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causes a direct change in cardiac structure, the 
occurrence of hypertrophy, and fibrosis.20
Ammirati et al.1 stated that CAD can cause 
a decrease in GLS due to systolic dysfunction 
resulting from permanent damage from myocytes 
that turn into nonfunctional fibrotic tissue or 
dysfunctional myocytes. However, this study 
has shown different results. From the bivariate 
analysis, it was found that 23.5% of the patients 
with CAD had a decrease in GLS, with a 
PR of 0.818 and a p value of 0.675 (95% CI 
0.426–1.573). The analysis was continued to 
multivariate analysis despite the p value ≥0.25 
because CAD is an important parameter toward 
a decrease in GLS. This study also shows that 
there is no statistical relationship between CAD 
and decreased GLS. The results of this study 
are different from those of prior studies as the 
CAD diagnoses were established based only on 
the patients’ medical records and not by the gold 
standard of an angiographic examination. This 
allows for a false negative on the incidence of 
CAD. Based on ESC 2013 guidelines, patients 
with age ≥60 years, male and female, with or 
without symptoms have a pretest probability of 
intermediate risk that requires further evaluation 
using a stress test to diagnose the presence or 
absence of CAD.21 GLS itself is a significantly 
strong predictor of stenosis in stable CAD with 
a mean value of -17% and an OR of 1.25 per 1% 
reduction in GLS.22
According to Mahalle et al.10 and Miller et 
al.11, patients with dyslipidemia have a 2.26 times 
greater risk of a decrease in GLS, compared to 
patients without dyslipidemia. However, those 
studies are contrary to our finding. From the 
multivariate analysis, it was found that there is 
a statistically significant relationship between 
dyslipidemia and decreased GLS, with an 
OR of 0.401 and a p value of 0.011 (95% CI 
0.199–0.808). This indicates that dyslipidemia 
is a protective factor against a decrease in 
GLS. Other studies have shown that GLS has a 
negative correlation with several risk factors, one 
of which is dyslipidemia, especially in children.23 
Vitarelli et al.24 stated that children and young 
adults with dyslipidemia have more severe left 
ventricular disorders characterized by a decrease 
in GLS. The study used subjects with a mean age 
of 10.48 (SD 3.42). This significant difference 
is probably due to the characteristics of the 
subjects from different studies, especially with 
regard to the age and history of dyslipidemia. 
The subjects of this study were selected based 
only on their medical records, with no cholesterol 
check performed alongside the echocardiography 
examination.
CONCLUSION
From this study, the mean value of GLS 
in elderly is -21.6% (minimum value -5.3% 
and maximum value 29.9%). The factors that 
influence the decrease of GLS are frailty and 
diabetes mellitus.
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